卡拉生物有限公司

簡介

本頁面提供了有關 Bruce Kovner 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Bruce Kovner已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:SBBP / Strongbridge Biopharma plc 10% Owner 0
US:MTEM / Molecular Templates, Inc. Director 2,052,991
US:KALA / KALA BIO, Inc. 10% Owner 0
0
US:SNTA / Synta Pharmaceuticals, Inc. Director, 10% Owner 340,970
如何解讀這些圖表

以下圖表顯示了在Bruce Kovner進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

KALA / KALA BIO, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 KALA / KALA BIO, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2017-07-20 KALA CDK ASSOCIATES, L.L.C. 215,000 15.0000 4,300 750.0000 3,225,000 56 1326.5 2,478,950 76.87
2017-07-20 KALA CDK ASSOCIATES, L.L.C. 215,000 15.0000 4,300 750.0000 3,225,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

KALA / KALA BIO, Inc. Insider Trades
KALA / KALA BIO, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 KALA / KALA BIO, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

KALA / KALA BIO, Inc. Insider Trades
MDGL / Madrigal Pharmaceuticals, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 KALA / KALA BIO, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2015-04-06 SNTA Kovner Bruce 6,857,143 1.7500 6,857,143 1.7500 12,000,000 731
2014-09-30 SNTA Kovner Bruce 300,000 3.0771 300,000 3.0771 923,130
2014-04-11 SNTA Kovner Bruce 1,250,000 4.0100 1,250,000 4.0100 5,012,500
2013-11-13 SNTA Kovner Bruce 1,600,000 3.7500 1,600,000 3.7500 6,000,000
2013-11-13 SNTA Kovner Bruce 3,400,000 3.7500 3,400,000 3.7500 12,750,000
2013-06-27 SNTA Kovner Bruce 150,000 4.7101 150,000 4.7101 706,515
2013-06-26 SNTA Kovner Bruce 300,000 4.6531 300,000 4.6531 1,395,930
2013-06-25 SNTA Kovner Bruce 200,000 4.3473 200,000 4.3473 869,460
2013-06-24 SNTA Kovner Bruce 200,000 4.4296 200,000 4.4296 885,920
2013-06-21 SNTA Kovner Bruce 50,000 4.2304 50,000 4.2304 211,520
2013-06-18 SNTA Kovner Bruce 200,000 3.9958 200,000 3.9958 799,160
2013-06-06 SNTA Kovner Bruce 738,900 4.3131 738,900 4.3131 3,186,950
2013-06-05 SNTA Kovner Bruce 756,000 4.7113 756,000 4.7113 3,561,743
2013-06-04 SNTA Kovner Bruce 505,100 4.9924 505,100 4.9924 2,521,661
2012-11-14 SNTA Kovner Bruce 10,500 6.9532 10,500 6.9532 73,009
2012-11-12 SNTA Kovner Bruce 27,200 6.8915 27,200 6.8915 187,449
2012-06-29 SNTA Kovner Bruce 910,000 5.4498 910,000 5.4498 4,959,318
2012-01-06 SNTA Kovner Bruce 1,136,363 4.4000 1,136,363 4.4000 4,999,997

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
MDGL / Madrigal Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 KALA / KALA BIO, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2015-12-08 SNTA Kovner Bruce 873,624 0.3700 873,624 0.3700 323,241 224
2015-12-08 SNTA Kovner Bruce 496,015 0.3700 496,015 0.3700 183,526
2015-12-07 SNTA Kovner Bruce 64 0.4100 64 0.4100 26
2015-12-07 SNTA Kovner Bruce 36 0.4100 36 0.4100 15
2015-12-04 SNTA Kovner Bruce 97,978 0.4124 97,978 0.4124 40,406
2015-12-04 SNTA Kovner Bruce 55,629 0.4124 55,629 0.4124 22,941
2015-12-03 SNTA Kovner Bruce 167,394 0.4139 167,394 0.4139 69,284
2015-12-03 SNTA Kovner Bruce 95,040 0.4139 95,040 0.4139 39,337
2015-12-02 SNTA Kovner Bruce 438,588 0.4272 438,588 0.4272 187,365
2015-12-02 SNTA Kovner Bruce 249,015 0.4272 249,015 0.4272 106,379
2015-12-01 SNTA Kovner Bruce 306,625 0.4302 306,625 0.4302 131,910
2015-12-01 SNTA Kovner Bruce 174,091 0.4302 174,091 0.4302 74,894
2015-11-30 SNTA Kovner Bruce 408,546 0.4335 408,546 0.4335 177,105
2015-11-30 SNTA Kovner Bruce 231,959 0.4335 231,959 0.4335 100,554
2015-11-27 SNTA Kovner Bruce 596,132 0.4950 596,132 0.4950 295,085
2015-11-27 SNTA Kovner Bruce 338,463 0.4950 338,463 0.4950 167,539
2015-11-25 SNTA Kovner Bruce 959,149 0.4881 959,149 0.4881 468,161
2015-11-25 SNTA Kovner Bruce 544,571 0.4881 544,571 0.4881 265,805
2015-11-24 SNTA Kovner Bruce 343,246 0.4413 343,246 0.4413 151,474
2015-11-24 SNTA Kovner Bruce 194,883 0.4413 194,883 0.4413 86,002
2015-11-23 SNTA Kovner Bruce 405,324 0.4369 405,324 0.4369 177,086
2015-11-23 SNTA Kovner Bruce 230,129 0.4369 230,129 0.4369 100,543
2015-11-20 SNTA Kovner Bruce 146,886 0.4431 146,886 0.4431 65,085
2015-11-20 SNTA Kovner Bruce 83,397 0.4431 83,397 0.4431 36,953
2015-11-19 SNTA Kovner Bruce 992,953 0.5050 992,953 0.5050 501,441
2015-11-19 SNTA Kovner Bruce 115,896 0.4617 115,896 0.4617 53,509
2015-11-19 SNTA Kovner Bruce 65,802 0.4617 65,802 0.4617 30,381
2015-11-18 SNTA Kovner Bruce 108,154 0.4329 108,154 0.4329 46,820
2015-11-17 SNTA Kovner Bruce 700,618 0.4220 700,618 0.4220 295,661
2015-11-16 SNTA Kovner Bruce 15,530 0.4352 15,530 0.4352 6,759
2015-11-13 SNTA Kovner Bruce 507,788 0.4324 507,788 0.4324 219,568
2015-11-12 SNTA Kovner Bruce 733,564 0.4741 733,564 0.4741 347,783
2015-11-11 SNTA Kovner Bruce 1,080,941 0.4979 1,080,941 0.4979 538,201
2015-11-10 SNTA Kovner Bruce 1,397,114 0.5505 1,397,114 0.5505 769,111
2015-11-09 SNTA Kovner Bruce 2,225,054 0.6086 2,225,054 0.6086 1,354,168

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Bruce Kovner 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2022-01-05 2021-10-05 4 SBBP Strongbridge Biopharma plc
Ordinary Shares Warrant (right to buy) 		J - Other -2,220,000 0 -100.00
2022-01-05 2021-10-05 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		J - Other -8,060,682 0 -100.00
2020-09-21 2020-09-18 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 6,000 8,060,682 0.07 2.20 13,200 17,733,500
2020-09-21 2020-09-17 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 1,473,377 8,054,682 22.39 2.25 3,315,098 18,123,034
2019-11-25 2019-11-21 4 MTEM Molecular Templates, Inc.
Common Stock 		P - Purchase 468,750 2,052,991 29.59 8.00 3,750,000 16,423,928
2018-12-28 2018-12-26 4 MTEM Molecular Templates, Inc.
Common Stock 		P - Purchase 25,000 1,584,241 1.60 3.45 86,250 5,465,631
2018-12-28 2018-12-27 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 18,200 6,581,305 0.28 3.98 72,434 26,192,936
2018-12-28 2018-12-26 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 31,197 6,563,105 0.48 4.00 124,698 26,233,387
2018-12-21 2018-12-21 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 90,612 6,531,908 1.41 3.95 357,990 25,806,262
2018-12-21 2018-12-20 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 146,467 6,441,296 2.33 4.00 585,385 25,743,928
2018-09-27 2018-09-25 4 MTEM Molecular Templates, Inc.
Common Stock 		P - Purchase 545,454 1,559,241 53.80 5.50 2,999,997 8,575,826
2018-08-09 2018-08-08 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 360,995 6,294,829 6.08 4.93 1,778,514 31,012,734
2018-08-01 2018-07-30 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 70,000 5,933,834 1.19 4.66 326,466 27,674,215
2018-07-27 2018-07-27 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 92,400 5,863,384 1.60 4.85 448,140 28,437,412
2018-07-27 2018-07-27 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 116,900 5,771,434 2.07 4.63 541,048 26,711,928
2018-07-27 2018-07-26 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 39,800 5,654,534 0.71 4.94 196,727 27,949,796
2018-07-27 2018-07-24 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 150,000 5,614,734 2.74 4.92 737,265 27,596,979
2018-07-23 2018-07-23 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 20,400 5,464,734 0.37 4.95 100,980 27,050,433
2018-07-23 2018-07-20 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 21,100 5,444,334 0.39 4.97 104,795 27,039,829
2018-07-23 2018-07-19 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 14,000 5,423,234 0.26 4.98 69,747 27,018,009
2018-07-18 2018-07-16 4 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		P - Purchase 11,200 5,409,234 0.21 4.97 55,629 26,867,124
2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		10,795,988
2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		10,795,988
2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		10,795,988
2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 		10,795,988
2017-08-10 3 MTEM Molecular Templates, Inc.
Common Stock 		2,027,574
2017-08-10 3 MTEM Molecular Templates, Inc.
Common Stock 		2,027,574
2017-08-10 3 MTEM Molecular Templates, Inc.
Common Stock 		2,027,574
2017-08-10 3 MTEM Molecular Templates, Inc.
Common Stock 		2,027,574
2017-08-10 3 MTEM Molecular Templates, Inc.
Common Stock 		2,027,574
2017-07-21 2017-07-20 4/A KALA Kala Pharmaceuticals, Inc.
Series C Convertible Preferred Stock 		C - Conversion -2,858,086 0 -100.00
2017-07-21 2017-07-20 4/A KALA Kala Pharmaceuticals, Inc.
Common Stock 		P - Purchase 215,000 763,755 39.18 15.00 3,225,000 11,456,325
2017-07-21 2017-07-20 4/A KALA Kala Pharmaceuticals, Inc.
Common Stock 		C - Conversion 548,755 548,755
2017-07-21 2017-07-20 4/A KALA Kala Pharmaceuticals, Inc.
Series C Convertible Preferred Stock 		C - Conversion -2,858,086 0 -100.00
2017-07-21 2017-07-20 4/A KALA Kala Pharmaceuticals, Inc.
Common Stock 		P - Purchase 215,000 763,755 39.18 15.00 3,225,000 11,456,325
2017-07-21 2017-07-20 4/A KALA Kala Pharmaceuticals, Inc.
Common Stock 		C - Conversion 548,755 548,755
2017-07-20 2017-07-20 4 KALA Kala Pharmaceuticals, Inc.
Common Stock 		P - Purchase 215,000 215,000 15.00 3,225,000 3,225,000
2016-07-12 2016-07-12 4 CPXX Celator Pharmaceuticals Inc
WARRANT 		J - Other -889,403 0 -100.00
2016-07-12 2016-07-12 4 CPXX Celator Pharmaceuticals Inc
WARRANT 		J - Other -34,647 0 -100.00
2016-07-12 2016-07-12 4 CPXX Celator Pharmaceuticals Inc
Common Stock 		U - Other -564,222 0 -100.00 30.25 -17,067,716
2016-07-12 2016-07-12 4 CPXX Celator Pharmaceuticals Inc
Common Stock 		U - Other -1,591,750 0 -100.00 30.25 -48,150,438
2016-06-22 2016-06-21 4 CPXX Celator Pharmaceuticals Inc
Common Stock 		G - Gift -1,926 1,591,750 -0.12
2016-06-22 2016-06-21 4 CPXX Celator Pharmaceuticals Inc
Common Stock 		G - Gift 564,222 564,222
2016-06-22 2016-06-21 4 CPXX Celator Pharmaceuticals Inc
Common Stock 		G - Gift -564,222 1,593,676 -26.15
2016-06-22 2016-06-21 4 CPXX Celator Pharmaceuticals Inc
Common Stock 		G - Gift -88,571 2,157,898 -3.94
2015-12-08 2015-12-08 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -496,015 340,970 -59.26 0.37 -183,526 126,159
2015-12-08 2015-12-08 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -873,624 600,548 -59.26 0.37 -323,241 222,203
2015-12-08 2015-12-07 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -36 836,985 0.00 0.41 -15 343,164
2015-12-08 2015-12-07 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -64 1,474,172 0.00 0.41 -26 604,411
2015-12-08 2015-12-04 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -55,629 837,021 -6.23 0.41 -22,941 345,187
2015-12-08 2015-12-04 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -97,978 1,474,236 -6.23 0.41 -40,406 607,975
2015-12-04 2015-12-02 4 CPXX Celator Pharmaceuticals Inc
Warrant 		P - Purchase 38,805 889,403 4.56 0.24 9,313 213,457
2015-12-04 2015-12-02 4 CPXX Celator Pharmaceuticals Inc
Warrant 		P - Purchase 34,647 34,647 0.24 8,315 8,315
2015-12-03 2015-12-03 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -95,040 892,650 -9.62 0.41 -39,337 369,468
2015-12-03 2015-12-03 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -167,394 1,572,214 -9.62 0.41 -69,284 650,739
2015-12-03 2015-12-02 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -249,015 987,690 -20.14 0.43 -106,379 421,941
2015-12-03 2015-12-02 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -438,588 1,739,608 -20.14 0.43 -187,365 743,161
2015-12-03 2015-12-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -174,091 1,236,705 -12.34 0.43 -74,894 532,030
2015-12-03 2015-12-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -306,625 2,178,196 -12.34 0.43 -131,910 937,060
2015-11-30 2015-11-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -231,959 1,410,796 -14.12 0.43 -100,554 611,580
2015-11-30 2015-11-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -408,546 2,484,821 -14.12 0.43 -177,105 1,077,170
2015-11-30 2015-11-27 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -338,463 1,642,755 -17.08 0.50 -167,539 813,164
2015-11-30 2015-11-27 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -596,132 2,893,367 -17.08 0.50 -295,085 1,432,217
2015-11-30 2015-11-25 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -544,571 1,981,218 -21.56 0.49 -265,805 967,033
2015-11-30 2015-11-25 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -959,149 3,489,499 -21.56 0.49 -468,161 1,703,224
2015-11-24 2015-11-24 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -194,883 2,525,789 -7.16 0.44 -86,002 1,114,631
2015-11-24 2015-11-24 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -343,246 4,448,648 -7.16 0.44 -151,474 1,963,188
2015-11-24 2015-11-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -230,129 2,720,672 -7.80 0.44 -100,543 1,188,662
2015-11-24 2015-11-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -405,324 4,791,894 -7.80 0.44 -177,086 2,093,578
2015-11-20 2015-11-20 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -83,397 2,950,801 -2.75 0.44 -36,953 1,307,500
2015-11-20 2015-11-20 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -146,886 5,197,218 -2.75 0.44 -65,085 2,302,887
2015-11-20 2015-11-19 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -65,802 3,034,198 -2.12 0.46 -30,381 1,400,889
2015-11-20 2015-11-19 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -115,896 5,344,104 -2.12 0.46 -53,509 2,467,373
2015-11-20 2015-11-19 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -992,953 0 -100.00 0.50 -501,441
2015-11-20 2015-11-18 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -108,154 992,953 -9.82 0.43 -46,820 429,849
2015-11-17 2015-11-17 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -700,618 1,101,107 -38.89 0.42 -295,661 464,667
2015-11-17 2015-11-16 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -15,530 1,801,725 -0.85 0.44 -6,759 784,111
2015-11-17 2015-11-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -507,788 1,817,255 -21.84 0.43 -219,568 785,781
2015-11-12 2015-11-12 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -733,564 2,325,043 -23.98 0.47 -347,783 1,102,303
2015-11-12 2015-11-11 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -1,080,941 3,058,607 -26.11 0.50 -538,201 1,522,880
2015-11-12 2015-11-10 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -1,397,114 4,139,548 -25.23 0.55 -769,111 2,278,821
2015-11-12 2015-11-09 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		S - Sale -2,225,054 5,536,662 -28.67 0.61 -1,354,168 3,369,612
2015-10-02 2015-09-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -4,000,000 11,399,464 -25.97
2015-10-02 2015-09-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other 4,000,000 4,000,000
2015-10-02 2015-09-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -120,854 0 -100.00
2015-10-02 2015-09-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other 120,854 15,399,464 0.79
2015-07-02 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy) 		A - Award 20,000 20,000
2015-07-02 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 4,545 3,092,677 0.15
2015-07-02 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 4,545 3,092,677 0.15
2015-07-02 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 22,727 3,083,587 0.74
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -354,146 120,854 -74.56
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -475,000 0 -100.00
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -475,000 0 -100.00
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -475,000 0 -100.00
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -125,000 0 -100.00
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -125,000 0 -100.00
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other -250,000 0 -100.00
2015-07-02 2015-06-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		J - Other 2,279,146 2,279,146
2015-04-08 2015-04-06 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 6,857,143 15,278,610 81.42 1.75 12,000,000 26,737,568
2014-11-26 2014-11-25 4 CPXX Celator Pharmaceuticals Inc
WARRANT 		P - Purchase 121,587 850,598 16.68 0.60 72,952 510,359
2014-11-21 2014-11-20 4 CPXX Celator Pharmaceuticals Inc
WARRANT 		P - Purchase 100,000 729,011 15.90 0.75 75,000 546,758
2014-10-01 2014-09-30 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 300,000 8,421,467 3.69 3.08 923,130 25,913,696
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy) 		A - Award 10,000 10,000
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 1,219 3,060,860 0.04
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 1,219 3,060,860 0.04
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 9,756 3,058,422 0.32
2014-04-14 2014-04-11 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 1,250,000 8,121,467 18.19 4.01 5,012,500 32,567,083
2013-11-15 2013-11-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 3,400,000 7,649,803 80.00 3.75 12,750,000 28,686,761
2013-11-15 2013-11-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 1,600,000 1,600,000 3.75 6,000,000 6,000,000
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy) 		A - Award 10,000 10,000
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 1,000 6,180,330 0.02
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 1,000 6,180,330 0.02
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 8,000 6,178,330 0.13
2013-07-01 2013-06-27 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 150,000 3,100,000 5.08 4.71 706,515 14,601,310
2013-06-27 2013-06-26 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 300,000 2,950,000 11.32 4.65 1,395,930 13,726,645
2013-06-27 2013-06-25 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 200,000 2,650,000 8.16 4.35 869,460 11,520,345
2013-06-25 2013-06-24 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 200,000 2,450,000 8.89 4.43 885,920 10,852,520
2013-06-25 2013-06-21 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 50,000 2,250,000 2.27 4.23 211,520 9,518,400
2013-06-20 2013-06-18 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 200,000 2,200,000 10.00 4.00 799,160 8,790,760
2013-06-06 2013-06-06 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 738,900 2,000,000 58.59 4.31 3,186,950 8,626,200
2013-06-06 2013-06-05 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 756,000 1,261,100 149.67 4.71 3,561,743 5,941,420
2013-06-06 2013-06-04 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 505,100 505,100 4.99 2,521,661 2,521,661
2013-05-09 3 NONE Celator Pharmaceuticals Inc
Common Stock 		2,246,469
2012-12-14 2012-12-12 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 2,325,581 3,273,281 245.39 8.60 19,999,997 28,150,217
2012-11-14 2012-11-14 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 10,500 947,700 1.12 6.95 73,009 6,589,548
2012-11-14 2012-11-12 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 27,200 937,200 2.99 6.89 187,449 6,458,714
2012-07-27 2012-07-25 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 3,081,664 8,006,852 62.57 6.49 19,999,999 51,964,469
2012-07-02 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy) 		A - Award 10,000 10,000
2012-07-02 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 914 4,925,188 0.02
2012-07-02 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 914 4,925,188 0.02
2012-07-02 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		A - Award 7,312 4,923,360 0.15
2012-07-02 2012-06-29 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 475,000 475,000
2012-07-02 2012-06-29 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 475,000 475,000
2012-07-02 2012-06-29 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 475,000 475,000
2012-07-02 2012-06-29 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 475,000 475,000
2012-07-02 2012-06-29 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift -1,900,000 4,916,048 -27.88
2012-07-02 2012-06-29 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 910,000 6,816,048 15.41 5.45 4,959,318 37,146,098
2012-01-10 2012-01-06 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		P - Purchase 1,136,363 5,906,048 23.82 4.40 4,999,997 25,986,611
2012-01-10 2011-12-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 125,000 125,000
2012-01-10 2011-12-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 125,000 125,000
2012-01-10 2011-12-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 125,000 125,000
2012-01-10 2011-12-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift 125,000 125,000
2012-01-10 2011-12-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock 		G - Gift -500,000 4,769,685 -9.49
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）